McKesson Corporation to Announce First Quarter Fiscal 2026 Earnings

IRVING, Texas – June 26, 2025 – McKesson Corporation (NYSE: MCK), a global leader in healthcare services, today announced its plans to release financial results for the first quarter of fiscal year 2026. The highly anticipated earnings report will be made public after market close on Wednesday, August 6, 2025. This announcement sets the stage for investors and analysts to gain crucial insights into the company's performance during the period ending June 30, 2025.

Following the release of its financial statements, McKesson will host a live webcast of its earnings conference call. The call is scheduled for 4:30 PM Eastern Time on the same day, August 6, 2025. During this webcast, McKesson's executive leadership team is expected to discuss the company's financial results, provide an overview of operational highlights, and offer forward-looking guidance for the remainder of fiscal year 2026. This interactive session will also include a question-and-answer segment, allowing analysts and institutional investors to directly engage with management.

Accessing the Earnings Webcast

Investors and interested parties can access the live audio webcast of the earnings conference call through McKesson's dedicated Investor Relations website. A replay of the webcast will also be archived on the site for those unable to attend the live session. This ensures broad accessibility to the company's financial disclosures and management commentary.

Importance of Q1 Fiscal 2026 Results

The first quarter fiscal 2026 results are particularly significant as they will provide an early indication of McKesson's trajectory for the new fiscal year. Investors will be closely watching several key metrics, including:

• Revenue Growth: Performance across its diverse segments, including pharmaceutical distribution, medical-surgical distribution, and oncology and specialty care.
• Profitability: Gross margins, operating income, and net income, reflecting efficiency and cost management.
• Cash Flow: Operating cash flow and free cash flow, indicating the company's ability to generate cash from its core operations.
• Guidance: Any updates to full-year fiscal 2026 financial outlook, which can significantly influence investor sentiment and stock performance.

McKesson's performance is often seen as a bellwether for the broader healthcare distribution sector. Its results can reflect trends in drug pricing, healthcare utilization, and supply chain dynamics. Given the ongoing evolution in healthcare policy and technology, the company's strategic initiatives and their impact on financial results will be a focal point.

Market Context and Investment Insights

McKesson operates in a dynamic healthcare landscape, characterized by increasing demand for pharmaceuticals and medical supplies, alongside pressures on healthcare costs. The company's diversified business model, spanning pharmaceutical distribution, medical-surgical distribution, and healthcare technology solutions, positions it uniquely within the industry. Investors will be keen to understand how McKesson is navigating supply chain complexities, inflationary pressures, and evolving regulatory environments.

For investors, the upcoming earnings call presents an opportunity to:

• Assess Operational Efficiency: Evaluate how McKesson is managing its extensive supply chain and optimizing its distribution networks.
• Understand Strategic Priorities: Gain clarity on the company's investments in technology, automation, and specialty care, which are crucial for long-term growth.
• Gauge Market Position: Understand McKesson's competitive standing relative to peers and its ability to capture market share in key segments.
• Evaluate Dividend Sustainability: For income-focused investors, the earnings report will offer insights into the company's financial health and its capacity to sustain or grow its dividend.

Analysts will likely adjust their price targets and ratings based on the reported figures and management's outlook. A strong earnings report, coupled with optimistic guidance, could provide a positive catalyst for MCK stock. Conversely, any significant misses or cautious outlooks could lead to downward revisions.

About McKesson Corporation

McKesson Corporation is a diversified healthcare services leader dedicated to improving the health of patients globally. The company partners with pharmaceutical manufacturers, providers, pharmacies, governments, and other organizations to deliver right products, at the right time, to the right patients. McKesson's solutions help its customers improve their financial, operational, and clinical performance. The company's commitment to innovation and efficiency plays a critical role in the healthcare ecosystem, ensuring the reliable and safe delivery of essential medical products and services across the globe. Its extensive network and technological capabilities underpin its position as a vital component of the healthcare supply chain.

Investors are encouraged to mark their calendars for August 6, 2025, to stay informed on McKesson's latest financial performance and strategic direction.